These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 9865560)

  • 1. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
    Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
    Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin injection after biliary sphincterotomy.
    Gorelick A; Barnett J; Chey W; Anderson M; Elta G
    Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin may predict the outcome of endoscopic sphincterotomy in episodic functional post-cholecystectomy biliary pain.
    Murray W; Kong S
    Scand J Gastroenterol; 2010 May; 45(5):623-7. PubMed ID: 20156033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
    Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
    Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction.
    Geenen JE; Hogan WJ; Dodds WJ; Toouli J; Venu RP
    N Engl J Med; 1989 Jan; 320(2):82-7. PubMed ID: 2643038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder.
    Linder JD; Klapow JC; Linder SD; Wilcox CM
    Am J Gastroenterol; 2003 Aug; 98(8):1738-43. PubMed ID: 12907327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.
    Wehrmann T; Schmitt TH; Arndt A; Lembcke B; Caspary WF; Seifert H
    Aliment Pharmacol Ther; 2000 Nov; 14(11):1469-77. PubMed ID: 11069318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manometrically-guided endoscopic injection of botulinum toxin for esophageal achalasia: a pilot trial.
    Wehrmann T; Schmitt T; Dietrich CF; Caspary WF; Seifert H
    Z Gastroenterol; 2000 Nov; 38(11):899-903. PubMed ID: 11132536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?
    Arguedas MR; Linder JD; Wilcox CM
    Endoscopy; 2004 Feb; 36(2):174-8. PubMed ID: 14765316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endoscopic treatment of dyskinesia of the Oddi's sphincter].
    Suárez Morán E
    Rev Gastroenterol Mex; 1998; 63(4 Suppl 1):S69-73. PubMed ID: 10068728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction.
    Freeman ML; Gill M; Overby C; Cen YY
    J Clin Gastroenterol; 2007 Jan; 41(1):94-102. PubMed ID: 17198071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction.
    Lin OS; Soetikno RM; Young HS
    Am J Gastroenterol; 1998 Oct; 93(10):1833-6. PubMed ID: 9772040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
    Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
    Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sphincter of Oddi disfunction in "idiopathic" recurrent pancreatitis].
    Wehrmann T; Zipf A; Caspary WF; Jung M
    Dtsch Med Wochenschr; 1996 Jun; 121(24):781-7. PubMed ID: 8654212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis.
    Muehldorfer SM; Hahn EG; Ell C
    Endoscopy; 1997 Feb; 29(2):120-4. PubMed ID: 9101150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies.
    Khashab MA; Watkins JL; McHenry L; Lazzell-Pannell L; Schmidt S; Sherman S; Lehman GA; Fogel EL
    Endoscopy; 2010 May; 42(5):369-74. PubMed ID: 19967632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic management of sphincter of Oddi dysfunction in children.
    Varadarajulu S; Wilcox CM
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):526-30. PubMed ID: 16707975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis.
    Wehrmann T; Wiemer K; Lembcke B; Jung M
    Z Gastroenterol; 1995 Nov; 33(11):662-8. PubMed ID: 8600663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report.
    Banerjee B; Miedema B; Saifuddin T; Marshall JB
    Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):194-6. PubMed ID: 10803999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.